{"PubmedArticle": [{"MedlineCitation": {"InvestigatorList": [], "SpaceFlightMission": [], "CitationSubset": ["IM"], "KeywordList": [], "GeneralNote": [], "OtherAbstract": [], "OtherID": [], "PMID": "3436505", "DateCompleted": {"Year": "1988", "Month": "03", "Day": "28"}, "DateRevised": {"Year": "2022", "Month": "03", "Day": "21"}, "Article": {"Language": ["ger"], "ELocationID": [], "ArticleDate": [], "Journal": {"ISSN": "0016-5751", "JournalIssue": {"Volume": "47", "Issue": "12", "PubDate": {"Year": "1987", "Month": "Dec"}}, "Title": "Geburtshilfe und Frauenheilkunde", "ISOAbbreviation": "Geburtshilfe Frauenheilkd"}, "ArticleTitle": "[Effect of a parenteral ozone-oxygen mixture on the concentration of immunoglobulins (IgA, IgG, IgM), of vitamin A and lysozyme activity in patients with cervical cancer].", "Pagination": {"StartPage": "343", "EndPage": "345", "MedlinePgn": "343-5"}, "Abstract": {"AbstractText": ["In the literature you can find several therapeutic possibilities in the treatment of carcinoma by additive ozone therapy. We investigated the consequences of ozone therapy for the immunological status, lysozyme and vitamin A. 21 women with progressive cervical cancer (Stage III, IV) got besides the conventional irradiation therapy also an additive ozone therapy. After irradiation and ozone therapy a small decrease in IgG, IgA and IgM can be seen. A statistical significance could not be evaluated. There was no difference to the control group in lysozyme and vitamin A."]}, "AuthorList": [{"AffiliationInfo": [{"Identifier": [], "Affiliation": "I. Univ.-Frauenklinik Wien."}], "Identifier": [], "LastName": "Enzelsberger", "ForeName": "H", "Initials": "H"}, {"AffiliationInfo": [], "Identifier": [], "LastName": "Metka", "ForeName": "M", "Initials": "M"}, {"AffiliationInfo": [], "Identifier": [], "LastName": "Salzer", "ForeName": "H", "Initials": "H"}], "PublicationTypeList": ["English Abstract", "Journal Article"], "VernacularTitle": "Der Einfluss von parenteraler Ozon-Sauerstoff-Gemisch-Applikation auf die Konzentration von Immunoglobulin (IgA, IgG, IgM), von Vitamin A und die Aktivit\u00e4t von Lysozym bei Patientinnen mit Zervixkarzinom."}, "MedlineJournalInfo": {"Country": "Germany", "MedlineTA": "Geburtshilfe Frauenheilkd", "NlmUniqueID": "0370732", "ISSNLinking": "0016-5751"}, "ChemicalList": [{"RegistryNumber": "0", "NameOfSubstance": "Cobalt Radioisotopes"}, {"RegistryNumber": "0", "NameOfSubstance": "Immunoglobulins"}, {"RegistryNumber": "11103-57-4", "NameOfSubstance": "Vitamin A"}, {"RegistryNumber": "66H7ZZK23N", "NameOfSubstance": "Ozone"}, {"RegistryNumber": "EC 3.2.1.17", "NameOfSubstance": "Muramidase"}], "MeshHeadingList": [{"QualifierName": ["immunology", "radiotherapy"], "DescriptorName": "Carcinoma, Squamous Cell"}, {"QualifierName": ["therapeutic use"], "DescriptorName": "Cobalt Radioisotopes"}, {"QualifierName": [], "DescriptorName": "Combined Modality Therapy"}, {"QualifierName": [], "DescriptorName": "Female"}, {"QualifierName": [], "DescriptorName": "Humans"}, {"QualifierName": ["metabolism"], "DescriptorName": "Immunoglobulins"}, {"QualifierName": ["blood"], "DescriptorName": "Muramidase"}, {"QualifierName": ["administration & dosage"], "DescriptorName": "Ozone"}, {"QualifierName": [], "DescriptorName": "Radioisotope Teletherapy"}, {"QualifierName": ["immunology", "radiotherapy"], "DescriptorName": "Uterine Cervical Neoplasms"}, {"QualifierName": ["blood"], "DescriptorName": "Vitamin A"}]}, "PubmedData": {"ReferenceList": [], "History": [{"Year": "1987", "Month": "12", "Day": "1"}, {"Year": "1987", "Month": "12", "Day": "1", "Hour": "0", "Minute": "1"}, {"Year": "1987", "Month": "12", "Day": "1", "Hour": "0", "Minute": "0"}], "PublicationStatus": "ppublish", "ArticleIdList": ["3436505"]}}], "PubmedBookArticle": []}